BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34196000)

  • 21. Central, But Not Peripheral, Circulating Tumor Cells are Prognostic in Patients Undergoing Resection of Colorectal Cancer Liver Metastases.
    Connor AA; McNamara K; Al-Sukhni E; Diskin J; Chan D; Ash C; Lowes LE; Allan AL; Zogopoulos G; Moulton CA; Gallinger S
    Ann Surg Oncol; 2016 Jul; 23(7):2168-75. PubMed ID: 26714949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Disease-Free Interval Between Resection of Primary Colorectal Malignancy and the Detection of Hepatic Metastases Predicts Disease Recurrence But Not Overall Survival.
    Höppener DJ; Nierop PMH; van Amerongen MJ; Olthof PB; Galjart B; van Gulik TM; de Wilt JHW; Grünhagen DJ; Rahbari NN; Verhoef C
    Ann Surg Oncol; 2019 Sep; 26(9):2812-2820. PubMed ID: 31147988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Population-based SEER analysis of survival in colorectal cancer patients with or without resection of lung and liver metastases.
    Siebenhüner AR; Güller U; Warschkow R
    BMC Cancer; 2020 Mar; 20(1):246. PubMed ID: 32293337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between primary tumor characteristics and histopathological growth pattern of liver metastases in colorectal cancer.
    Bohlok A; Tonneau C; Vankerckhove S; Craciun L; Lucidi V; Bouazza F; Hendlisz A; Van Laethem JL; Larsimont D; Vermeulen P; Donckier V; Demetter P
    Clin Exp Metastasis; 2023 Oct; 40(5):431-440. PubMed ID: 37453024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic impact of additive chemotherapy after curative resection of metachronous colorectal liver metastasis: a single-centre retrospective study.
    Kelm M; Schollbach J; Anger F; Wiegering A; Klein I; Germer CT; Schlegel N; Kunzmann V; Löb S
    BMC Cancer; 2021 May; 21(1):490. PubMed ID: 33941104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prognostic impact of resection margin status varies according to the genetic and morphological evaluation (GAME) score for colorectal liver metastasis.
    Wang HW; Wang LJ; Jin KM; Bao Q; Li J; Wang K; Xing BC
    J Surg Oncol; 2021 Sep; 124(4):619-626. PubMed ID: 34081792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemotherapy and targeted therapy for patients with initially unresectable colorectal liver metastases, focusing on conversion hepatectomy and long-term survival.
    Beppu T; Miyamoto Y; Sakamoto Y; Imai K; Nitta H; Hayashi H; Chikamoto A; Watanabe M; Ishiko T; Baba H
    Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S405-13. PubMed ID: 24570379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significance of Herpesvirus Entry Mediator Expression in Human Colorectal Liver Metastasis.
    Sasaki Y; Hokuto D; Inoue T; Nomi T; Yoshikawa T; Matsuo Y; Koyama F; Sho M
    Ann Surg Oncol; 2019 Nov; 26(12):3982-3989. PubMed ID: 31313042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors influencing recurrence following initial hepatectomy for colorectal liver metastases.
    Hallet J; Sa Cunha A; Adam R; Goéré D; Bachellier P; Azoulay D; Ayav A; Grégoire E; Navarro F; Pessaux P;
    Br J Surg; 2016 Sep; 103(10):1366-76. PubMed ID: 27306949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colorectal Cancer Liver Metastases and Concurrent Extrahepatic Disease Treated With Resection.
    Leung U; Gönen M; Allen PJ; Kingham TP; DeMatteo RP; Jarnagin WR; D'Angelica MI
    Ann Surg; 2017 Jan; 265(1):158-165. PubMed ID: 28009741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Favorable outcome after repeat resection for colorectal liver metastases.
    Saiura A; Yamamoto J; Koga R; Takahashi Y; Takahashi M; Inoue Y; Ono Y; Kokudo N
    Ann Surg Oncol; 2014 Dec; 21(13):4293-9. PubMed ID: 24962942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term characteristics of 5-year survivors after liver resection for colorectal metastases.
    Tanaka K; Shimada H; Ueda M; Matsuo K; Endo I; Togo S
    Ann Surg Oncol; 2007 Apr; 14(4):1336-46. PubMed ID: 17235718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pulmonary metastasectomy in colorectal cancer patients with previously resected liver metastasis: pooled analysis.
    Salah S; Ardissone F; Gonzalez M; Gervaz P; Riquet M; Watanabe K; Zabaleta J; Al-Rimawi D; Toubasi S; Massad E; Lisi E; Hamed OH
    Ann Surg Oncol; 2015; 22(6):1844-50. PubMed ID: 25326396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is complete liver resection without resection of synchronous lung metastases justified?
    Mise Y; Kopetz S; Mehran RJ; Aloia TA; Conrad C; Brudvik KW; Taggart MW; Vauthey JN
    Ann Surg Oncol; 2015 May; 22(5):1585-92. PubMed ID: 25373535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer.
    Margonis GA; Buettner S; Andreatos N; Kim Y; Wagner D; Sasaki K; Beer A; Schwarz C; Løes IM; Smolle M; Kamphues C; He J; Pawlik TM; Kaczirek K; Poultsides G; Lønning PE; Cameron JL; Burkhart RA; Gerger A; Aucejo FN; Kreis ME; Wolfgang CL; Weiss MJ
    JAMA Surg; 2018 Jul; 153(7):e180996. PubMed ID: 29799910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low infiltration of peritumoral regulatory T cells predicts worse outcome following resection of colorectal liver metastases.
    Nakagawa K; Tanaka K; Homma Y; Nojiri K; Kumamoto T; Takeda K; Endo I
    Ann Surg Oncol; 2015 Jan; 22(1):180-6. PubMed ID: 25120248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clinical relevance of the Fong and the Nordlinger scores in the era of effective neoadjuvant chemotherapy for colorectal liver metastasis.
    Schreckenbach T; Malkomes P; Bechstein WO; Woeste G; Schnitzbauer AA; Ulrich F
    Surg Today; 2015 Dec; 45(12):1527-34. PubMed ID: 25563588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiogenic desmoplastic histopathological growth pattern as a prognostic marker of good outcome in patients with colorectal liver metastases.
    Galjart B; Nierop PMH; van der Stok EP; van den Braak RRJC; Höppener DJ; Daelemans S; Dirix LY; Verhoef C; Vermeulen PB; Grünhagen DJ
    Angiogenesis; 2019 May; 22(2):355-368. PubMed ID: 30637550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BRAF V600E potentially determines "Oncological Resectability" for "Technically Resectable" colorectal liver metastases.
    Kobayashi S; Takahashi S; Nomura S; Kojima M; Kudo M; Sugimoto M; Konishi M; Gotohda N; Taniguchi H; Yoshino T
    Cancer Med; 2021 Oct; 10(20):6998-7011. PubMed ID: 34535965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-Term Outcomes of Conversion Hepatectomy for Initially Unresectable Colorectal Liver Metastases.
    Maeda Y; Shinohara T; Nagatsu A; Futakawa N; Hamada T
    Ann Surg Oncol; 2016 Feb; 23 Suppl 2():S242-8. PubMed ID: 25749931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.